PARABOLIC DRUGS LTD - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal

Parabolic Drugs Ltd - Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal

Download	< Back
16 Jan 2021
Compliance/Disclosure requirement pursuant to Regulation 30(2) read with clause m of Sub-Part A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Parabolic Drugs Limited which was undergone through Corporate Insolvency Resolution Process (CIRP).
View all announcements for Parabolic Drugs Ltd	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us